BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33360690)

  • 1. Thyroid Cancer Identified After Positron Emission Tomography (PET) Shows Aggressive Histopathology.
    Beck T; Zhang N; Shah A; Khoncarly S; McHenry C; Jin J
    J Surg Res; 2021 Apr; 260():245-250. PubMed ID: 33360690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natural history of the benign thyroid nodule: what is the appropriate follow-up strategy?
    Ajmal S; Rapoport S; Ramirez Batlle H; Mazzaglia PJ
    J Am Coll Surg; 2015 Jun; 220(6):987-92. PubMed ID: 25667137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of BRAF mutation detection in fine-needle aspiration biopsy samples read as "suspicious for papillary thyroid carcinoma".
    Jara SM; Bhatnagar R; Guan H; Gocke CD; Ali SZ; Tufano RP
    Head Neck; 2015 Dec; 37(12):1788-93. PubMed ID: 24989827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of thyroid incidentalomas on positron emission tomographic scans among thyroidectomy patients.
    Amir A; Karls S; Sands N; Forest VI; Hier M; Gologan O; Payne R
    J Otolaryngol Head Neck Surg; 2011 Oct; 40(5):391-5. PubMed ID: 22420394
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Ciappuccini R; Licaj I; Lasne-Cardon A; Babin E; de Raucourt D; Blanchard D; Bastit V; Saguet-Rysanek V; Lequesne J; Peyronnet D; Grellard JM; Clarisse B; Bardet S
    Thyroid; 2021 May; 31(5):800-809. PubMed ID: 33183159
    [No Abstract]   [Full Text] [Related]  

  • 6. Multifocality related factors in papillary thyroid carcinoma.
    Gur EO; Karaisli S; Haciyanli S; Kamer E; Genc H; Atahan K; Haciyanli M
    Asian J Surg; 2019 Jan; 42(1):297-302. PubMed ID: 30585170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid Microcalcifications in the Absence of Identifiable Nodules and Their Association With Thyroid Cancer.
    Whittle C; García M; Horvath E; Slater J; Carrasco C
    J Ultrasound Med; 2019 Jan; 38(1):97-102. PubMed ID: 29781213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High incidence of thyroid cancer in focal thyroid incidentaloma detected by 18F-fluorodeoxyglucose [corrected] positron emission tomography in relatively young healthy subjects: results of 3-year follow-up.
    Ohba K; Nishizawa S; Matsushita A; Inubushi M; Nagayama K; Iwaki H; Matsunaga H; Suzuki S; Sasaki S; Oki Y; Okada H; Nakamura H
    Endocr J; 2010; 57(5):395-401. PubMed ID: 20160400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benign thyroid nodules in pediatric patients: determining best practices for repeat ultrasound evaluations.
    Hodax JK; Bowerman K; Quintos JB
    J Pediatr Endocrinol Metab; 2019 Aug; 32(8):895-901. PubMed ID: 31271555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRAF analysis by fine needle aspiration biopsy of thyroid nodules improves preoperative identification of papillary thyroid carcinoma and represents a prognostic factor. A mono-institutional experience.
    Pelizzo MR; Boschin IM; Barollo S; Pennelli G; Toniato A; Zambonin L; Vianello F; Piotto A; Ide EC; Pagetta C; Sorgato N; Torresan F; Girelli ME; Nacamulli D; Mantero F; Mian C
    Clin Chem Lab Med; 2011 Feb; 49(2):325-9. PubMed ID: 21175381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with Indeterminate Thyroid Nodules at Cytology and Cancer at Histology Have a More Favorable Outcome Compared with Patients with Suspicious or Malignant Cytology.
    Rago T; Scutari M; Loiacono V; Tonacchera M; Scuotri G; Romani R; Proietti A; Piaggi P; Elisei R; Basolo F; Latrofa F; Vitti P
    Thyroid; 2018 Oct; 28(10):1318-1324. PubMed ID: 30132418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between positron emission tomography-computed tomography imaging and histopathological features of thyroid incidentalomas detected during follow-up for primary malignancy.
    Oven BB; Kilicoglu ZG; Bilici A; Tatoglu MT; Canberk S; Tilki M; Vardar FA
    J Cancer Res Ther; 2019; 15(3):589-595. PubMed ID: 31169225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma.
    Paek SH; Kim BS; Kang KH; Kim HS
    World J Surg Oncol; 2017 Nov; 15(1):202. PubMed ID: 29132392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of BRAF mutation and SUV
    Ozderya A; Temizkan S; Gul AE; Ozugur S; Sargin M; Aydin K
    Endocrine; 2017 Jan; 55(1):215-222. PubMed ID: 27696232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-fluorodeoxyglucose positron emission tomography-computed tomography for suspected recurrent papillary thyroid cancer: early experience at Sunnybrook Health Sciences Centre.
    Dahele M; Ung YC; Ehrlich L; Silverberg J; Balogh J; Wong CS
    J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):712-7. PubMed ID: 19128681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction Table and Nomogram as Tools for Diagnosis of Papillary Thyroid Carcinoma: Combined Analysis of Ultrasonography, Fine-Needle Aspiration Biopsy, and BRAF V600E Mutation.
    Kim SK; Lee JH; Woo JW; Park I; Choe JH; Kim JH; Kim JS
    Medicine (Baltimore); 2015 May; 94(21):e760. PubMed ID: 26020381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Incidental Thyroid Nodules in Cancer Patients.
    Cansu GB; Yılmaz N; Toru S; Sarı R; Gökhan Ocak G; Arıcı C; Altunbaş HA; Balcı MK
    J Natl Med Assoc; 2017 Winter; 109(4):299-306. PubMed ID: 29173938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of 18F-fluorodeoxyglucose positron emission tomography in preoperative assessment of cytologically indeterminate thyroid nodules.
    Sebastianes FM; Cerci JJ; Zanoni PH; Soares J; Chibana LK; Tomimori EK; de Camargo RY; Izaki M; Giorgi MC; Eluf-Neto J; Meneghetti JC; Pereira MA
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4485-8. PubMed ID: 17684046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of ultrasonographic/clinical profile, cytology, and BRAF V600E mutation evaluation in thyroid nodule screening for malignancy: a prospective study.
    Rossi M; Buratto M; Bruni S; Filieri C; Tagliati F; Trasforini G; Rossi R; Beccati MD; Degli Uberti EC; Zatelli MC
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2354-61. PubMed ID: 22535974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of predictability of F-18 fluorodeoxyglucose-PET/CT in the recurrence of papillary thyroid carcinoma.
    Kim SK; So Y; Chung HW; Yoo YB; Park KS; Hwang TS; Kim B; Lee WW
    Cancer Med; 2016 Oct; 5(10):2756-2762. PubMed ID: 27539659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.